A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

South Africa might be cushioned from the global fallout in reduced funding for HIV prevention and treatment, but it has not been spared the effects, a global health report has found.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

Millions of lives and decades of progress hang in the balance,” says the president of the International AIDS Society (IAS) ...

8 July 2025 (Kigali, Rwanda) – IAS 2025, the 13th IAS Conference on HIV Science, taking place in Kigali, Rwanda, and virtually from 13 to 17 July, will feature an array of studies that address the ...

Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...

Following the news from the DOH that the Philippines has the most number of new HIV cases in the Western Pacific, with an ...

The Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global AIDS response is in crisis after a major funding collapse at the start of 2025 threatens to reverse decades of ...